This review is based on our recent experience in producing the first commercial recombinant proteins in transgenic plants. We bring forward the issues that have to be considered in the process of selecting and developing a winning transgenic plant production system. From the production point of view
Recombinant proteins from transgenic plants
✍ Scribed by Eva Franken; Ute Teuschel; Rüdiger Hain
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 675 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0958-1669
No coin nor oath required. For personal study only.
✦ Synopsis
Transgenic plants can express a wide variety of foreign genes and offer the opportunity of large-scale protein production in agricultural systems. The recombinant protein can serve both ex situ and in situ purposes. Due to significant progress in plant molecular biology, many different plant species can now be transformed and are even capable of producing very complex proteins such as antibodies or vaccines. Furthermore, recombinant proteins can mediate resistance against microbial pathogens, such as fungi or viruses, or protect transgenic plants from insect pests.
📜 SIMILAR VOLUMES
## Abstract Tobacco has proven to be a promising alternative for the production of recombinant therapeutic proteins and offers numerous advantages over other plants as a host system. However, the recovery and purification steps needed to obtain a protein at high recovery and purity have not been we
Transgenic plants are showing considerable potential for the economic production of proteins, with a few already being marketed. Recent clinical trials of pharmaceuticals produced from transgenic plants are encouraging, with plant glycans showing reassuringly poor immunogenicity. Our increasing unde